PHS
PFM Health Sciences’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4M | Sell |
483,105
-73,440
| -13% | -$7.67M | 4.29% | 4 |
|
|
2025
Q1 | $64.9M | Buy |
556,545
+89,118
| +19% | +$10.4M | 4.71% | 5 |
|
|
2024
Q4 | $39.5M | Hold |
467,427
| – | – | 2.45% | 8 |
|
|
2024
Q3 | $42M | Hold |
467,427
| – | – | 2.38% | 14 |
|
|
2024
Q2 | $37.6M | Hold |
467,427
| – | – | 1.86% | 15 |
|
|
2024
Q1 | $37.3M | Hold |
467,427
| – | – | 1.75% | 18 |
|
|
2023
Q4 | $37.2M | Sell |
467,427
-55,783
| -11% | -$4.44M | 2.23% | 15 |
|
|
2023
Q3 | $36.6M | Buy |
523,210
+27,628
| +6% | +$1.93M | 1.72% | 27 |
|
|
2023
Q2 | $35.6M | Sell |
495,582
-110,499
| -18% | -$7.94M | 1.38% | 32 |
|
|
2023
Q1 | $37.4M | Sell |
606,081
-486,750
| -45% | -$30M | 1.65% | 26 |
|
|
2022
Q4 | $84.3M | Sell |
1,092,831
-566,902
| -34% | -$43.7M | 3.02% | 6 |
|
|
2022
Q3 | $74.1M | Buy |
1,659,733
+299,137
| +22% | +$13.3M | 2.68% | 8 |
|
|
2022
Q2 | $52.1M | Buy |
+1,360,596
| New | +$52.1M | 1.99% | 15 |
|